A-share debut in the Year of the Dragon: The Shanghai Composite Index stood above 2,900, AI set off a rising tide, and more than 4,000 stocks rose

On February 19, A-shares made their debut in the Year of the Dragon, standing at 2,900 points. At the close, the Shanghai Composite Index rose 1.56% to 2,910.54 points, closing at the highest point of the day, the Shenzhen Component Index rose 0.93% to close at 8,902.33 points, and the ChiNext Index rose 1.13% to close at 1,746.42 points.

On the whole day of February 19, northbound funds sold a net of 6.375 billion yuan throughout the day, including a net purchase of 178 million yuan in Shanghai-Hong Kong Stock Connect, a net sale of 6.553 billion yuan in Shenzhen-Hong Kong Stock Connect, and a net outflow of 5.056 billion yuan in main funds.

Yang Delong, chief economist of Qianhai Open Source Fund, told the China Times: "The market has a good start after the holiday, and continues the rising trend before the holiday, which is a positive signal, indicating that the market is gradually recovering and the market trend is gradually reversing under the promotion of many favorable policies." ”

More than 4,000 stocks rose

On February 19, from the perspective of the A-share market, the number of gainers reached 4,258 and 1,037 fell, with a good ratio of ups and downs, reflecting the market's enthusiasm for longs. Among them, there are 272 daily limits and 250 natural daily limits.

Yang Delong said: "During the Spring Festival, the external market generally rose, especially Hong Kong stocks rose for three consecutive trading days before the opening of A-shares, laying a solid foundation for A-shares to achieve a good start to the year. There has been a sharp rebound in many sectors, and the market's money-making effect has increased significantly. ”

The full-day turnover of the Shanghai and Shenzhen stock markets was 957.3 billion yuan, a decrease of 60 billion yuan from the previous trading day. After standing at 2700 points, 2800 points, and 2900 points in a row, the shrinkage rose on the daily line, which means that the market needs to adjust and take a breath.

On the disk, with the birth of Sora, AI concept stocks are red across the board, multimodal model concept, WEB3.0, ChatGPT, virtual human, AIGC and other sectors have risen comprehensively; optical communication concepts continued to strengthen in the afternoon, Zhongji Xuchuang, Tianfu Communication, Xinyisheng, and Liante Technology all rose and stopped by 20%; film and television stocks collectively strengthened, and Chinese Online, Bohui Technology, Silk Road Vision, and Tangde Film and Television rose by 20%.

The Sora discussion continues to heat up. One of the inventors of Sora today, Xie Saining, a genius boy who graduated from Shanghai Jiao Tong University, responded in the circle of friends. "Sora is my previous intern and OpenAI's world-changing masterpiece, and it has nothing to do with me," he said. ”

He further said: "How can AI ensure the smooth and accurate dissemination of knowledge and creativity, so that everyone has the 'superpower' to tell and disseminate their own stories, and achieve a sense of information equality. This is not the same order of magnitude as before the technology matured, generating beautiful pictures with little fuss, and the truth capture and the story told in Black Mirror are likely to become reality soon. ”

Diet pills rush up and down

During the spring, "Hot and Hot" was screened and became the box office champion of the Spring Festival, and Jia Ling's inspirational topic of losing 100 pounds was frequently searched. This has also aroused the capital market's longing for the concept of weight loss pills after the holiday, but after today's opening, the core weight loss pills concept stocks of A-shares have come out of the market of rising and falling, and there is no limit in the sector.

Among them, Changshan Pharmaceutical Co., Ltd. once rose 18.3% after opening today, and then gradually fell back to 9.77 yuan / share as of the close, up 12.43%. The company's original Class 1.1 innovative drug ebenatide, which is a long-acting GLP-1 preparation with semaglutide, is currently approved for clinical indication for the treatment of type 2 diabetes.

Shuanglu Pharmaceutical opened up 4.74% at the open, and closed at 8.62 yuan per share, up 2.13%. The company's liraglutide R&D is in the third phase of data collation.

Hanyu Pharmaceuticals opened up 11.82% and closed down to 9.38%. At present, the company's liraglutide API has received commercial batch orders from overseas pharmaceutical companies, and the US FDA application of liraglutide preparation has entered the final review stage.

Nuotai Biotech opened as high as 7.74% and finally closed up 4.98%. Semaglutide produced by the company has passed the GMP compliance inspection for export.

From the perspective of Hong Kong stocks, Innovent announced on the Hong Kong Stock Exchange on February 7 that the China National Medical Products Administration has officially accepted the first new drug application for the glucagon-like peptide-1 receptor (GLP-1R)/glucagon receptor (GCGR) dual agonist Masdotide has been accepted by the Center for Drug Evaluation of the China National Medical Products Administration for long-term weight control in adult obese or overweight patients.

However, as the first weight loss drug concept stock approved for new drug listing, after rising 11% during the Spring Festival, on February 19, Innovent Biologics fell into a state of adjustment at the opening and closed down 3.49%.

It is worth noting that last Friday, Eli Lilly, one of the "weight loss pill duo", hit an all-time high of $782.06 per share. Morgan Stanley predicts that Eli Lilly is on track to become the first biopharmaceutical company to reach a market capitalization of $1 trillion with Orforglipron, an oral GLP-1 drug in trial.

The SFC issued its first fine at the beginning of the year

Before the holiday, the official website of the China Securities Regulatory Commission published the first administrative penalty decision in 2024, mainly involving Ruihua Certified Public Accountants (hereinafter referred to as Ruihua) and related responsible personnel, who failed to be diligent and conscientious in the audit of Kangdexin's annual reports from 2015 to 2017 and were fined 17.83 million yuan. In addition, Silxin voluntarily withdrew its IPO application due to inflated revenue and net profit, and was punished by the CSRC for fraudulent issuance.

Yu Fenghui, an expert consultant of the Hong Kong Top 100 Research Center, told the China Times: "For the credibility and norms of the accounting industry, such a high fine undoubtedly has a significant warning effect, indicating that the regulator has a zero-tolerance attitude towards the dereliction of duty of intermediaries." At the same time, in addition to the economic loss, Ruihua's brand image and social trust will also suffer a major blow. ”

Yang Delong said: "During the Spring Festival, the China Securities Regulatory Commission severely cracked down on some violations of laws and regulations, and punished the relevant persons in charge of a number of violations, which is very happy. Wu Qing, the new chairman of the China Securities Regulatory Commission, has many years of experience in securities and fund supervision, and is well versed in the securities market and the operation of financial institutions. Chairman Wu Qing's appointment has greatly boosted the confidence of investors, and it is expected that through further deepening reforms, we will build a healthy and strong capital market. ”

For the market outlook, Yang Delong believes: "Now the year of the dragon market has kicked off, the beginning of the year to achieve a good start is also a good sign, in the year of the rabbit many investors have losses, the market to make money is poor, but to the year of the dragon market may usher in better investment opportunities, the strength of economic recovery will be further enhanced, the policy will be further increased, including the gradual relaxation of real estate control policies, more and more cities to cancel purchase restrictions." ”

Editor-in-charge: Shuai Kecong Editor-in-chief: Xia Shencha